The Injury Severity Score (ISS) in patients with head trauma

A clinical trial to comparison of the Injury Severity Score (ISS) between cannabis, opium, and benzodiazepine consumption and healthy individuals in patients with head trauma

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016100514872N3

Enrollment

Registered

2016-11-06

Start date

2016-11-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with head trauma. Unspecified injury of head

Interventions

Intervention 1: Control group: Evaluation of cannabis, opium, and benzodiazepine urinary levels with immunochromatography and the Injury Severity Score (ISS) with questionnaire in healthy individuals

Diagnosis

Control group: Evaluation of cannabis, opium, and benzodiazepine urinary levels with immunochromatography and the Injury Severity Score (ISS) with questionnaire in healthy individuals with head trauma

Intervention group: Evaluation of cannabis, opium, and benzodiazepine urinary levels with immunochromatography and the Injury Severity Score (ISS) with questionnaire in cannabis, opium, and benzodiaze

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with head trauma are referring to Shahid Hashemi Nezhad Hospital in Mashhad; Glasgow Coma Scale (GCS) between 9 to 13. Exclusion criteria: Patients who not consent to measure the specific substance urinary levels; patient with anuria; patient with shock.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cannabis, opium, and benzodiazepine urinary levels. Timepoint: After refer to hospital. Method of measurement: Immunochromatography.	—

Secondary

Measure	Time frame
Injury Severity Score (ISS). Timepoint: After refer to hospital. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVawoud Sharifi

Mashhad University of Medical Sciences

sharifimd@mums.ac.ir+98 51 3852 5312

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026